Determinants of HIV-induced brain changes in three different periods of the early clinical course: A data mining analysis

NeuroImage: Clinical

Volumn 9, Issue , 2015, Pages 75-82

  Cao, Bokai ^a   Kong, Xiangnan ^b   Kettering, Casey ^c   Yu, Philip ^a   Ragin, Ann ^c  

^a University of Illinois at Chicago   (United States)

^b Worcester Polytechnic Institute   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Acute HIV; Corpus callosum; Cytokines; Data mining; MMP 1; Neuroinflammation

Indexed keywords

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN CORTEX; BRAIN FOURTH VENTRICLE; BRAIN INFECTION; BRAIN SIZE; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS CALLOSUM; DATA MINING; DIFFUSION TENSOR IMAGING; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LATERAL BRAIN VENTRICLE; MAGNETOENCEPHALOGRAPHY; MAJOR CLINICAL STUDY; MALE; NEUROANATOMY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; SUPPORT VECTOR MACHINE; SYSTEMIC CIRCULATION; THALAMUS; VIRUS CELL INTERACTION; VIRUS INHIBITION; WHITE MATTER; BLOOD; BRAIN; CEREBROSPINAL FLUID; HIV INFECTIONS; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

CYTOKINE;

ADULT; BRAIN; CYTOKINES; DATA MINING; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; SEVERITY OF ILLNESS INDEX; SUPPORT VECTOR MACHINE;

EID: 84939547572     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2015.07.012     Document Type: Article

References (76)

1. Ances B.M., and et al. Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain Neurology 73 9 2009 702 708 10.1212/WNL.0b013e3181b59a97 19720977
2. Anthony I.C., and Bell J.E. The neuropathology of HIV/AIDS Int. Rev. Psychiatry 20 1 2008 15 24 10.1080/09540260701862037 18240059
3. Basser P.J., and Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI J. Magn. Reson. B 111 3 1996 209 219 10.1006/jmrb.1996.0086 8661285
4. Basser P.J., and Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI J. Magn. Reson. B 111 3 1996 209 219 10.1006/jmrb.1996.0086 8661285
5. Becker J.T., and et al. Subcortical brain atrophy persists even in HAART-regulated HIV disease Brain Imaging Behav. 5 2 2011 77 85 10.1007/s11682-011-9113-8 21264551
6. Becker J.T., and et al. Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease J. Neurosci. Methods 206 2 2012 176 182 10.1016/j.jneumeth.2012.02.022 22414786
7. Becker J.T., and et al. Functional connectivity measured with magnetoencephalography identifies persons with HIV disease Brain Imaging Behav. 6 3 2012 366 373 10.1007/s11682-012-9149-4 22328062
8. Becker K.M., and et al. Decreased MEG beta oscillations in HIV-infected older adults during the resting state J. Neurovirol. 19 6 2013 586 594 10.1007/s13365-013-0220-8 24297500
9. Borrow P., and Bhardwaj N. Innate immune responses in primary HIV-1 infection Curr. Opin. H.I.V. A.I.D.S. 3 1 2008 36 44 10.1097/COH.0b013e3282f2bce7 19372942
10. Brew B.J. Lost in translation: again, another failed neuroprotection trial Neurol. 69 13 2007 1308 1309 10.1212/01.wnl.0000277530.05450.ff 17893290
11. Burdo T.H., and et al. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy J. Infect. Dis. 204 1 2011 154 163 10.1093/infdis/jir214 21628670
12. Cao B., and et al. Tensor-based multi-view feature selection with applications to brain diseases IEEE International Conference on Data Mining, Shenzhen, China 2014
13. Chang C.-C., and Lin C.-J. LIBSVM: a library for support vector machines A.C.M. Transactions Intell. Syst. Technol. 2 3 2011 1 27 10.1145/1961189.1961199
14. Chang C.-C., and Lin C.-J. LIBSVM: A Library for Support Vector Machines 2014 [Software] [cited 2015 January 1] available from: http://www.csie.ntu.edu.tw/~cjlin/libsvm/
15. Chiang M.C., and et al. 3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry Neuroimage 34 1 2007 44 60 10.1016/j.neuroimage.2006.08.030 17035049
16. Cohen R.A., and et al. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era J. Neurovirol. 16 1 2010 25 32 10.3109/13550280903552420 20113183
17. Conant K., and et al. Matrix metalloproteinase 1 interacts with neuronal integrins and stimulates dephosphorylation of Akt J. Biol. Chem. 279 9 2004 8056 8062 10.1074/jbc.M307051200 14679206
18. Cosenza-Nashat M.A., and et al. CD45 isoform expression in microglia and inflammatory cells in HIV-1 encephalitis Brain Pathol. 16 4 2006 256 265 10.1111/j.1750-3639.2006.00027.x 17107594
19. Davis L.E., and et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection Neurol. 42 9 1992 1736 1739 10.1212/WNL.42.9.1736 1513462
20. Deeks S.G., and et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load Blood 104 4 2004 942 947 10.1182/blood-2003-09-3333 15117761
21. Dhar A., and et al. Novel role of TGF-beta in differential astrocyte-TIMP-1 regulation: implications for HIV-1-dementia and neuroinflammation J. Neurosci. Res. 83 7 2006 1271 1280 10.1002/jnr.20787 16496359
22. Drucker H., and et al. Support vector regression machines Advances in Neural Information Processing Systems 9 1997 155 161
23. Ellis R., Heaton R., Letendre S., Badiee J., Munoz-Moreno J., Vaida F., Cliffford D., Gelman B., Simpson D., Grant I. Charter Group Higher CD4 nadir is associated with reduced rates of HIV-associated neurocognitive disorders in the CHARTER study: potential implications for early treatment initiation Conference on Retroviruses and Opportunistic Infections, San Francisco, CA 2010
24. Ellis R.J., and et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy A.I.D.S. 25 14 2011 1747 1751 10.1097/QAD.0b013e32834a40cd 21750419
25. Eugenin E.A., and et al. HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes Proc. Natl. Acad. Sci. U. S. A. 104 9 2007 3438 3443 10.1073/pnas.0611699104 17360663
26. Feeney E.R., and et al. The expression of cholesterol metabolism genes in monocytes from HIV-infected subjects suggests intracellular cholesterol accumulation J. Infect. Dis. 207 4 2013 628 637 10.1093/infdis/jis723 23204179
27. Fischl B., and et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain Neuron 33 3 2002 341 355 10.1016/S0896-6273(02)00569-X 11832223
28. Gartner S. HIV infection and dementia Science 287 5453 2000 602 604 10691542
29. Gartner S., and Liu Y. Insights into the role of immune activation in HIV neuropathogenesis J. Neurovirol. 8 2 2002 69 75 10.1080/13550280290049525 11935459
30. Gasper-Smith N., and et al. Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design J. Virol. 82 15 2008 7700 7710 10.1128/JVI.00605-08 18508902
31. Guyon I., and et al. Gene selection for cancer classification using support vector machines Mach. Learn. 46 1-3 2002 389 422
32. Haughey N.J., and et al. HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity J. Neurochem. 78 3 2001 457 467 10.1046/j.1471-4159.2001.00396.x 11483648
33. Kaul M. HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches Curr. Opin. Neurol. 22 3 2009 315 320 10.1097/WCO.0b013e328329cf3c 19300249
34. Kaul M., and Lipton S.A. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS J. Neuroimmune Pharmacol. 1 2 2006 138 151 10.1007/s11481-006-9011-9 18040780
35. Keating S.M., and et al. Lower-sensitivity and avidity modifications of the VITROS anti-HIV 1 + 2 assay for detection of recent HIV infections and incidence estimation J. Clin. Microbiol. 50 12 2012 3968 3976 10.1128/JCM.01454-12 23035182
36. Lamers S.L., and et al. HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues Infect. Genet. Evol. 11 1 2011 31 37 10.1016/j.meegid.2010.10.016 21055482
37. Le T., and et al. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy N. Engl. J. Med. 368 3 2013 218 230 10.1056/NEJMoa1110187 23323898
38. Lentz M.R., and et al. Alterations in brain metabolism during the first year of HIV infection J. Neurovirol. 17 3 2011 220 229 10.1007/s13365-011-0030-9 21494901
39. Lindl K.A., and et al. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities J. Neuroimmune Pharmacol. 5 3 2010 294 309 10.1007/s11481-010-9205-z 20396973
40. MacLean A.G., and et al. Activation of the blood-brain barrier by SIV (simian immunodeficiency virus) requires cell-associated virus and is not restricted to endothelial cell activation Biochem. Soc. Trans. 32 5 2004 750 752 10.1042/BST0320750
41. McMichael A.J., and et al. The immune response during acute HIV-1 infection: clues for vaccine development Nat. Rev. Immunol. 10 1 2010 11 23 10.1038/nri2674 20010788
42. Mellors J.W., and et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. [erratum in: science 1997 January 3; 275(5296):14] Science 272 5265 1996 1167 1170 10.1126/science.272.5265.1167 8638160
43. Nath A., and et al. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes: a hit and run phenomenon J. Biol. Chem. 274 24 1999 17098 17102 10.1074/jbc.274.24.17098 10358063
44. Olivetta E., and et al. HIV-1 Nef impairs key functional activities in human macrophages through CD36 downregulation PLOS One 9 4 2014 e93699 10.1371/journal.pone.0093699 24705461
45. Peluso M.J., and et al. Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection J. Infect. Dis. 207 11 2013 1703 1712 10.1093/infdis/jit088 23460748
46. Ragin A.B., and et al. Serum matrix metalloproteinase levels correlate with brain injury in human immunodeficiency virus infection J. Neurovirol. 15 3 2009 275 281 10.1080/13550280902913271 19444696
47. Ragin A.B., and et al. Biomarkers of neurological status in HIV infection: a 3-year study Proteomics Clin. Appl. 4 3 2010 295 303 10.1002/prca.200900083 21137050
48. Ragin A.B., and et al. Marked relationship between matrix metalloproteinase 7 and brain atrophy in HIV infection J. Neurovirol. 17 2 2011 153 158 10.1007/s13365-011-0018-5 21302026
49. Ransohoff R.M., and Brown M.A. Innate immunity in the central nervous system J. Clin. Invest. 122 4 2012 1164 1171 10.1172/JCI58644 22466658
50. Rumbaugh J., and et al. Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism F.A.S.E.B. J. 20 10 2006 1736 1738 10.1096/fj.05-5619fje 16807369
51. Schacker T., and et al. Clinical and epidemiologic features of primary HIV infection.[see comment][erratum appears in Ann intern Med 1997 January 15; 126(2):174] Ann. Intern. Med. 125 4 1996 257 264 10.7326/0003-4819-125-4-199608150-00001 8678387
52. Sevigny J.J., and et al. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia Neurol. 63 11 2004 2084 2090 10.1212/01.WNL.0000145763.68284.15 15596754
53. Sevigny J.J., and et al. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection Arch. Neurol. 64 1 2007 97 102 10.1001/archneur.64.1.97 17210815
54. Smith S.M., and et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis Neuroimage 17 1 2002 479 489 10.1006/nimg.2002.1040 12482100
55. Spudich S., and et al. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden J. Infect. Dis. 204 5 2011 753 760 10.1093/infdis/jir387 21844301
56. Stacey A.R., and et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections J. Virol. 83 8 2009 3719 3733 10.1128/JVI.01844-08 19176632
57. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior Annu. Rev. Cell Dev. Biol. 17 2001 463 516 10.1146/annurev.cellbio.17.1.463 11687497
58. Suryadevara R., and et al. Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia Glia 44 1 2003 47 56 10.1002/glia.10266 12951656
59. Tate D.F., and et al. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies J. Neurovirol. 17 4 2011 368 379 10.1007/s13365-011-0033-6 21556960
60. Thomas J.B., and et al. Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity Neurology 80 13 2013 1186 1193 10.1212/WNL.0b013e318288792b 23446675
61. Thompson M.A., and et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel JAMA 308 4 2012 387 402 10.1001/jama.2012.7961 22820792
62. Thompson P.M., and et al. Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline Proc. Natl. Acad. Sci. U. S. A. 102 43 2005 15647 15652 10.1073/pnas.0502548102 16227428
63. Thompson P.M., and et al. 3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS Neuroimage 31 1 2006 12 23 10.1016/j.neuroimage.2005.11.043 16427319
64. Valcour V., and et al. Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii aging with HIV cohort J. Neuroimmunol. 157 1-2 2004 197 202 10.1016/j.jneuroim.2004.08.029 15579298
65. Valcour V., and et al. Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection - the Hawaii aging with HIV cohort J. Neurovirol. 12 5 2006 387 391 10.1080/13550280600915339 17065131
66. Valcour V., and et al. Central nervous system viral invasion and inflammation during acute HIV infection J. Infect. Dis. 206 2 2012 275 282 10.1093/infdis/jis326 22551810
67. Valcour V., and et al. Central nervous system viral invasion and inflammation during acute HIV infection J. Infect. Dis. 206 2 2012 275 282 10.1093/infdis/jis326 22551810
68. Wang X., and et al. Abnormalities in resting-state functional connectivity in early human immunodeficiency virus infection Brain Connect. 1 3 2011 207 217 10.1089/brain.2011.0016 22433049
69. Wilson T.W., and et al. Abnormal MEG oscillatory activity during visual processing in the prefrontal cortices and frontal eye-fields of the aging HIV brain PLOS One 8 6 2013 e66241 10.137/journal.pone.0066241] [Pubmed: 23840428]
70. Wilson T.W., and et al. Functional brain abnormalities during finger-tapping in HIV-infected older adults: a magnetoencephalography study J. Neuroimmune Pharmacol. 8 4 2013 965 974 10.1007/s11481-013-9477-1 23749418
71. Wilson T.W., and et al. Multimodal neuroimaging evidence of alterations in cortical structure and function in HIV-infected older adults Hum. Brain Mapp. 36 3 2015 897 910 10.1002/hbm.22674 25376125
72. Wohlschlaeger J., and et al. White matter changes in HIV-1 infected brains: A combined gross anatomical and ultrastructural morphometric investigation of the corpus callosum Clin. Neurol. Neurosurg. 111 5 2009 422 429 10.1016/j.clineuro.2008.12.006 19185416
73. Wolff S.D., and Balaban R.S. Magnetization transfer imaging: practical aspects and clinical applications Radiology 192 3 1994 593 599 10.1148/radiology.192.3.8058919 8058919
74. Wu Y., and et al. Diffusion alterations in corpus callosum of patients with HIV A.J.N.R. Am. J. Neuroradiol. 27 3 2006 656 660 16552012
75. Wu Y., and et al. Whole brain and localized magnetization transfer measurements are associated with cognitive impairment in patients infected with human immunodeficiency virus A.J.N.R. Am. J. Neuroradiol. 29 1 2008 140 145 10.3174/ajnr.A0740 17928382
76. Yoshizawa T., Motonishi S., and Saitoh M. [Case of acute primary HIV infection with menigoencephalitis demonstrating high signal intensity of the bilateral globus pallidus in T2-weighted MRI] Rinsho Shinkeigaku 47 9 2007 597 600 18018620